Roger Appelqvist
Papers
2
Total Citations
29
H-Index
2
About
Roger Appelqvist is a leading figure in translational biobanking and respiratory biomarker research, whose work bridges high-throughput automation with clinical discovery. His key research areas include biobank infrastructure development, cancer and cardiovascular studies, and early detection of chronic obstructive pulmonary disease (COPD). Appelqvist’s major contribution is the design and validation of a semi-automated 384 high-density sample tube robot, which revolutionized biobank processing by enabling efficient, large-scale handling of clinical specimens for genomic and proteomic analysis. This innovation, detailed in his 2015 paper (16 citations), directly supports the postgenomic need for robust sample management in complex disease studies. In parallel, his 2016 protocol on COPD biomarkers (13 citations) addresses a critical public health challenge: identifying early pulmonary impairment in smokers before irreversible damage occurs. By focusing on biomarkers in smokers and former smokers, Appelqvist’s work provides a framework for early intervention in a disease that is the third leading cause of death worldwide. His achievements demonstrate a rare ability to integrate engineering solutions with clinical research, making high-quality biobanking accessible for large-scale cancer and cardiovascular studies. For students and researchers, Appelqvist exemplifies how methodological innovation can accelerate translational science from bench to bedside.
Research Focus
Key Achievements
Top Papers
- 1
- 2